|
PPRC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.773800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.814800E-01 |
| Normal-vs-Stage2 |
2.898000E-01 |
| Normal-vs-Stage3 |
8.741600E-01 |
| Normal-vs-Stage4 |
6.191000E-01 |
| Stage1-vs-Stage2 |
8.593500E-02 |
| Stage1-vs-Stage3 |
9.136400E-01 |
| Stage1-vs-Stage4 |
7.204200E-01 |
| Stage2-vs-Stage3 |
1.719230E-01 |
| Stage2-vs-Stage4 |
8.807800E-02 |
| Stage3-vs-Stage4 |
6.762200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.768600E-01 |
| Normal-vs-AfricanAmerican |
4.329400E-01 |
| Normal-vs-Asian |
3.468000E-01 |
| Caucasian-vs-AfricanAmerican |
5.822600E-01 |
| Caucasian-vs-Asian |
4.782600E-01 |
| AfricanAmerican-vs-Asian |
9.882000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.317200E-01 |
| Normal-vs-Female |
6.726200E-01 |
| Male-vs-Female |
1.621760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.053600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.800600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.139600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.964800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.442250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.504200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.074400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.318800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.012800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.424000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.053400E-01 |
| Classical-VS-Follicular |
7.7715611723761E-15 |
| Classical-VS-Other |
2.694000E-02 |
| Classical-VS-Normal |
8.138100E-02 |
| Tall-VS-Follicular |
1.74490999999E-05 |
| Tall-VS-Other |
4.943700E-02 |
| Tall-VS-Normal |
5.063400E-01 |
| Follicular-VS-Other |
6.940200E-01 |
| Follicular-VS-Normal |
5.754900E-04 |
| Other-VS-Normal |
2.205400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.453800E-01 |
| Normal-vs-N1 |
8.123800E-01 |
| N0-vs-N1 |
1.253960E-01 |
|
|
